First commercial deployment of synthetic biology for medicine has modest impact.
Highlights
C&EN: DMSO poses decomposition danger
17 September 2020Acids produced by heating dimethyl sulfoxide can trigger a runaway reaction.
C&EN: COVID-19 antigen assay set to triple US testing capacity
03 September 2020Abbott aims to produce 50 million of the 15-minute, $5 tests per month.
Nature: Can the history of pollution shape a better future?
01 September 2020The poisonous legacy of industry holds lessons, two books show.
C&EN: Saliva tests show promise for COVID-19 surveillance at universities and workplaces
23 August 2020Protocols developed at University of Illinois and Yale School of Public Health join growing list of spit-and-test diagnostics.
C&EN: Cryo-Electron Microscopy Reaches Resolution Milestone
18 August 2020Detailed protein structures are fuelingdrug-discovery efforts.
TESTIMONIALS
“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Philip Ball
Freelance Science Writer
